# COSENTYX

NDC: 0078-1070
Generic name: secukinumab
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20150121

FDA application: BLA125504

## Active ingredients

- SECUKINUMAB: 300 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77c4b13e-7df3-42d4-81db-3d0cddb7f67a